Thure Krarup Selected Research

Dietary Carbohydrates (Carbohydrate, Dietary)

1/2022	Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial.
1/2022	Long-term outcomes of dietary carbohydrate restriction for HbA1c reduction in type 2 diabetes mellitus are needed. Reply to Kang J and Ma E [letter].
1/2022	Weight-loss induced by carbohydrate restriction does not negatively affect health-related quality of life and cognition in people with type 2 diabetes: A randomised controlled trial.
1/2021	Effects of carbohydrate restriction on postprandial glucose metabolism, β-cell function, gut hormone secretion, and satiety in patients with Type 2 diabetes.
9/2018	Acute Effects of Dietary Carbohydrate Restriction on Glycemia, Lipemia and Appetite Regulating Hormones in Normal-Weight to Obese Subjects.
1/2015	Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thure Krarup Research Topics

Disease

34	Type 2 Diabetes Mellitus (MODY) 01/2022 - 09/2003
9	Weight Loss (Weight Reduction) 01/2022 - 04/2008
6	Chronic Pancreatitis 11/2012 - 09/2003
5	Body Weight (Weight, Body) 01/2022 - 06/2007
5	Hypoglycemia (Reactive Hypoglycemia) 01/2019 - 09/2003
4	Insulin Resistance 01/2022 - 09/2003
4	Weight Gain 02/2016 - 01/2013
4	Diabetes Mellitus 11/2008 - 09/2006
2	Obesity 01/2022 - 01/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 05/2021 - 12/2018
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2010 - 11/2008
1	Overweight 01/2022
1	Diabetes Complications 01/2022
1	Inflammation (Inflammations) 09/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2020
1	Hyperlipidemias (Hyperlipidemia) 09/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2015
1	Steatorrhea 01/2007
1	Bone Resorption 12/2003
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2002
1	Hyperaldosteronism (Conn Syndrome) 01/2002

Drug/Important Bio-Agent (IBA)

19	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2003
15	Insulin (Novolin)FDA Link 01/2022 - 09/2003
11	CarbohydratesIBA 01/2022 - 01/2018
9	Glucagon-Like Peptide 1 (GLP 1)IBA 05/2015 - 09/2003
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
8	Hormones (Hormone)IBA 01/2021 - 12/2003
7	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 02/2016
7	IncretinsIBA 05/2015 - 12/2006
6	Dietary Carbohydrates (Carbohydrate, Dietary)IBA 01/2022 - 01/2015
6	Peptides (Polypeptides)IBA 05/2015 - 12/2006
5	Exenatide (Byetta)FDA Link 12/2013 - 07/2008
3	Glucagon (Glukagon)FDA Link 09/2010 - 04/2008
2	Biphasic InsulinsIBA 01/2022 - 02/2016
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 12/2018
2	Blood Glucose (Blood Sugar)IBA 01/2015 - 07/2011
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2013 - 01/2013
2	EnzymesIBA 09/2010 - 01/2007
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 11/2008 - 07/2008
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	LipidsIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Nucleic AcidsIBA 09/2020
1	NAD (NADH)IBA 01/2020
1	Nonesterified Fatty Acids (NEFA)IBA 12/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2018
1	Cholecystokinin (Pancreozymin)IBA 09/2018
1	Insulin Aspart (NovoLog)FDA Link 02/2016
1	Insulin Detemir (Levemir)FDA Link 02/2016
1	GlucocorticoidsIBA 05/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2015
1	Interleukin-6 (Interleukin 6)IBA 11/2012
1	C-PeptideIBA 08/2010
1	Arginine (L-Arginine)FDA Link 08/2010
1	Glipizide (Glucotrol)FDA LinkGeneric 02/2009
1	KATP ChannelsIBA 02/2009
1	Adenosine Triphosphate (ATP)IBA 02/2009
1	Hypoglycemic Agents (Hypoglycemics)IBA 11/2008
1	Dipeptidyl-Peptidase IV InhibitorsIBA 11/2008
1	Liraglutide FDA Link 06/2007
1	Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA 12/2006
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 09/2006
1	CreatinineIBA 12/2003
1	Collagen Type I (Type I Collagen)IBA 12/2003
1	Glucagon-Like Peptides (Enteroglucagon)IBA 12/2003
1	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 12/2003

Therapy/Procedure

11	Therapeutics 01/2022 - 09/2003
8	High-Protein Diet 01/2022 - 01/2018
6	Injections 12/2013 - 07/2008
3	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 01/2022 - 01/2015
3	Glycemic Control 12/2013 - 06/2007
2	Subcutaneous Injections 12/2003 - 09/2003
1	High-Protein Low-Carbohydrate Diet (Atkins Diet) 12/2021
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2019
1	Fat-Restricted Diet (Diet, Fat Restricted) 01/2015
1	Adrenalectomy 01/2002